Literature DB >> 16368439

Intraperitoneal chemotherapy for women with advanced epithelial ovarian carcinoma.

Edward L Trimble, Michaele C Christian.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16368439     DOI： 10.1016/j.ygyno.2005.12.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  11 in total

1.  Phase I trial of intraperitoneal pemetrexed, cisplatin, and paclitaxel in optimally debulked ovarian cancer.

Authors:  Setsuko K Chambers; H-H Sherry Chow; Mike F Janicek; Janiel M Cragun; Kenneth D Hatch; Haiyan Cui; Cynthia Laughren; Mary C Clouser; Janice L Cohen; Heather M Wright; Nisreen Abu Shahin; David S Alberts
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

Review 2.  [Peritoneal carcinomatosis].

Authors:  I Königsrainer; S Beckert; T Lehmann; R Ladurner; B Brücher; A Königsrainer
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

3.  Modulation of p53 expression in cancer-associated fibroblasts prevents peritoneal metastasis of gastric cancer.

Authors:  Toshihiro Ogawa; Satoru Kikuchi; Motoyasu Tabuchi; Ema Mitsui; Yuta Une; Hiroshi Tazawa; Shinji Kuroda; Kazuhiro Noma; Toshiaki Ohara; Shunsuke Kagawa; Yasuo Urata; Toshiyoshi Fujiwara
Journal:  Mol Ther Oncolytics       Date:  2022-04-25       Impact factor: 6.311

4.  Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer.

Authors:  D S Alberts; M Markman; F Muggia; R F Ozols; E Eldermire; M A Bookman; T Chen; J Curtin; L M Hess; L Liebes; R C Young; E Trimble
Journal:  Gynecol Oncol       Date:  2006-10-27       Impact factor: 5.482

Review 5.  Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.

Authors:  J Spiliotis; E Halkia; E de Bree
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

6.  Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details.

Authors:  Koray Topgül; Mehmet Bilge Çetinkaya; N Çiğdem Arslan; Mustafa Kemal Gül; Murat Çan; Mahmut Fikret Gürsel; Dilek Erdem; Zafer Malazgirt
Journal:  Ulus Cerrahi Derg       Date:  2015-09-01

7.  Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.

Authors:  Devansu Tewari; James J Java; Ritu Salani; Deborah K Armstrong; Maurie Markman; Thomas Herzog; Bradley J Monk; John K Chan
Journal:  J Clin Oncol       Date:  2015-03-23       Impact factor: 44.544

8.  Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.

Authors:  Ying Gao; Zi Liu; Xi Chen; Wei Luo; Long Zhang; Juan Wang
Journal:  BMC Cancer       Date:  2011-10-11       Impact factor: 4.430

9.  Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience.

Authors:  Marie-Elisabeth Kajdi; Beatrice Beck-Schimmer; Ulrike Held; Reto Kofmehl; Kuno Lehmann; Michael Thomas Ganter
Journal:  World J Surg Oncol       Date:  2014-05-01       Impact factor: 2.754

10.  Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.

Authors:  Manuela Robella; Marco Vaira; Michele De Simone
Journal:  World J Surg Oncol       Date:  2016-04-29       Impact factor: 2.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.